IPEC e-newsletter - Excipients Insight June 2018 - 19-06-18


Inside this issue


IPEC Europe welcomes BMS as new member

IPEC Europe is delighted to welcome Bristol-Myers Squibb as a new member company this month.

The company says its medicines are helping millions of patients around the world in disease areas such as oncology, cardiovascular, immunoscience, fibrosis and others. It has built a pipeline of potential therapies, and is leveraging translational medicine and data analytics to understand how it can deliver the right medicine to the right patient at the right time to achieve the best outcome.

Through the Bristol-Myers Squibb Foundation, it also promotes health equity and seek to improve health outcomes of populations disproportionately affected by serious diseases and conditions, giving new hope to some of the world’s most vulnerable people. Each day, BMS' employees around the world work together for patients.




Copyright © 2005 - 2018 IPEC Europe - International Pharmaceutical Excipients Council